Norbert Scherbaum (psychiatrist)

from Wikipedia, the free encyclopedia
Norbert Scherbaum (2019)

Norbert Scherbaum (born July 29, 1961 in Essen ) is a German psychiatrist and university professor. He is professor for clinical addiction research at the University of Duisburg-Essen and medical director of the LVR-Klinikum Essen .

Life

After graduating from high school in Essen, Scherbaum studied medicine at the University of Essen and at the University of London from 1981 onwards, with a scholarship from the German National Academic Foundation . He completed his studies in 1987 in Essen. Scherbaum then did his military service as a medical officer in the Federal Air Force and conducted parallel research at the Psychological Institute of the University of Hamburg . He completed his training as a specialist in psychiatry and psychotherapy and as a specialist in child and adolescent psychiatry at the LVR clinics in Düsseldorf and Essen. Scherbaum completed his doctorate in 1991 at the University of Hamburg. From 1991 to 1994 he worked at the department for child and adolescent psychiatry at the LVR-Klinikum Essen under the direction of Christian Eggers .

In 1995 Scherbaum became senior physician in the general psychiatry department of the LVR clinic in Essen under head physician Markus Gastpar . In 1998 he spent several months researching at Brookhaven National Laboratory in the US state of New York. He specialized in particular in the field of addiction medicine and completed his habilitation in 2002 with work on the substitution therapy of opioid addicts .

In 2004 Scherbaum became director of the newly created clinic for dependent behavior and addiction medicine at the LVR-Klinikum Essen and professor for clinical addiction research at the University of Duisburg-Essen . Since 2013 he has also been director of the Clinic for Psychiatry and Psychotherapy. In 2014 he became the medical director of the clinic.

Scherbaum research in particular to look for medical aspects of opiate addiction , so to improve substitution treatment, the evaluation of Opiatentzugsbehandlung , detection and treatment of co-morbid mental disorders , evaluation of drug consumption rooms or "Turbo Withdrawal" . Other areas of research include the use of new psychoactive substances and the misuse of approved drugs such as anesthetics , opiate analgesics and anti-epileptics .

Norbert Scherbaum has been a member of the Federal Ministry of Health's expert committee for the evaluation of addictive substances since 2010 . Since 2011 he has been a member of the Addiction and Drugs Committee of the German Medical Association . The committee advises the board of directors of the German Medical Association on medical-scientific questions in connection with the subject of drugs.

honors and awards

  • "Top Doctors" in the Focus list of doctors

Publications

Books

  • The drug paperback. 5th, completely revised and expanded edition. Georg Thieme Verlag, Stuttgart 2017, ISBN 978-3-13-168725-8 .

As editor

  • with Andreas Heinz, Anil Batra and Euphrosyne Gouzoulis-Mayfrank: Neurobiology of Dependence: Basics and Consequences for Diagnosis and Therapy of Addictions. Kohlhammer, Stuttgart 2012, ISBN 978-3-17-021474-3 .

Articles in specialist journals (selection)

  • N. Scherbaum, U. Bonnet: Neurobiology of Opioid Addiction. In: The pain. Volume 32, 2018, pp. 483-494.
  • N. Scherbaum, J. Timm, F. Richter, U. Bonnet, J. Bombeck, S. Lajos, M. Specka: Outcome of a hepatitis B vaccination program for clients of a drug consumption facility. In: Journal of Clinical Virology. Volume 106, 2018, pp. 28-32.
  • N. Scherbaum, F. Schifano, U. Bonnet: New Psychoactive Substances (NPS) - a Challenge for the Addiction Treatment Services. In: Pharmacopsychiatry . Volume 50, 2017, pp. 116-122.
  • U. Bonnet, N. Scherbaum: How addictive are gabapentin and pregabalin? A systematic review. In: European Neuropsychopharmacology . Volume 27, 2017, pp. 1185-1215.
  • SM Apelt, N. Scherbaum, J. Goelz, M. Backmund, M. Soyka: Safety, Effectiveness and Tolerance of Buprenorphine-Naloxone in the Treatment of Opioid Dependence: Results from a Nationwide Non-Interventional Study in Routine Care. In: Pharmacopsychiatry . Volume 46, 2013, pp. 94-107.
  • H. Dirks, S. Esser, R. Borgmann, M. Wolter, E. Fischer, A. Potthoff, R. Jablonka, D. Schadendorf, N. Brockmeyer, N. Scherbaum: Substance use and sexual risk behavior among HIV-positive men who have sex with men in specialized out-patient clinics. In: HIV Medicine . Volume 13, 2012, pp. 533-540. link
  • U. Bonnet, N. Scherbaum: Cannabis-related disorders. In: Advances in Neurology Psychiatry. Volume 78, 2010, pp. 297-302.
  • N. Scherbaum, M. Specka, J. Bombeck, B. Marrziniak: Drug consumption facility as part of a primary health care center for problem drug users - which clients are attracted? In: International Journal of Drug Policy. Volume 20, 2009, pp. 447-449.
  • N. Scherbaum, M. Specka: Factors influencing the course of opiate addiction. In: International Journal of Methods in Psychiatric Research. Volume 17, Suppl 1, pp. S39-S44 2008.
  • N. Scherbaum, S. Klein, H. Kaube, P. Kienbaum, J. Peters, M. Gastpar: Alternative strategies of opiate detoxification: Evaluation of the so-called ultra-rapid detoxification. In: Pharmacopsychiatry. Volume 31, 1998, pp. 205-209.
  • N. Scherbaum, M. Gastpar: The substitution with methadone as a therapeutic approach in the treatment of opiate addicts. In: The neurologist . Vol. 62, 1991, pp. 529-535.

Individual evidence

  1. ↑ a b Curriculum Vitae Norbert Scherbaum . Taiwan Society of Internal Medicine, accessed February 1, 2020.
  2. ↑ a b New medical director at the LVR-Klinikum Essen . LVR press release, November 17, 2014.
  3. ↑ Speakers: Norbert Scherbaum . 2 ° International Scientific School. Novel Psychoactive Substances: focus on Novel Synthetic Opioids, October 2019. Retrieved February 2, 2020.
  4. ↑ Prof. Dr. med. Norbert Scherbaum is again a member of the "Narcotics Committee" . Press release of the LVR-Klinikum Essen, June 1, 2016. Accessed February 1, 2020.
  5. ↑ Announcement - experts in the committee according to § 1 Abs. 2 Narcotics Act (BtMG) and according to § 7 New Psychoactive Substances Act (NpSG) . Federal Ministry of Health, February 21, 2019. Accessed February 1, 2020.
  6. ↑ Prof. Dr. med. Norbert Scherbaum is again a member of the “Addiction and Drugs” working group . Press release LVR-Klinikum Essen, December 3, 2015. Accessed February 1, 2020.
  7. ↑ Committees of the German Medical Association. Election period 2019/2023 . Federal Medical Association, November 15, 2019, p. 41 (PDF file, accessed on February 1, 2020.
  8. ↑ Focus doctor list: four doctors from the LVR-Klinikum Essen are again among the top doctors in Germany . Press release of the LVR-Klinikum Essen from June 26, 2018, accessed on February 2, 2020 (PDF file)
  9. ↑ University Medicine Essen: 24 top doctors on the Focus list . Press release of the University Hospital Essen from July 14, 2019, accessed on February 3, 2020.
personal data
SURNAME Scherbaum, Norbert
BRIEF DESCRIPTION German psychiatrist and university professor
DATE OF BIRTH July 29, 1961
PLACE OF BIRTH eat